PitchBook News - Coinbase leads VC's crypto retreat

Obesity drug market's future in focus; mobility tech's fossil-free revolution; mapping France's muted VC ecosystem; Thrive Capital targets $3B fund
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC
January 9, 2024
The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data
In today's Daily Pitch, you'll find:
 
Today's Top Stories  
Coinbase leads VC retreat from crypto dealmaking
(Andriy Onufriyenko/Getty Images)
Burned by high-profile bankruptcies including FTX and BlockFi, crypto investors have pared down their dealmaking pace several-fold since the banner year of 2021.

Coinbase Ventures, for example, made 64 fewer investments in H2 2023 than in H2 2021. They're redirecting much of that unused dry powder to increase ownership shares in existing companies.

Others, including 10T Holdings, are buying secondary shares in blockchain companies on the cheap.
read more
 
Share: Email LinkedIn Twitter Facebook
Taking ridehailing to the next level
Do you remember the world before Uber and Lyft? From last-mile delivery to freight, the world of mobility tech has undergone transformative shifts just in the years since the early aughts.

Just as ridehailing companies turned the industry on its head in the 2010s, innovations to minimize jet fuel's carbon footprint and maximize EV battery effectiveness are set to boom as the world moves away from fossil fuels.

Along the way, we'll see self-driving startups zero in on trucking and rail use and an EV export tsunami from China, according to our latest Mobility Tech Overview, which dives into what's ahead for 11 sectors.
read the preview
 
Share: Email LinkedIn Twitter Facebook
 
Obesity drug market's future in focus
(Monster Ztudio/Shutterstock)
PitchBook senior analyst Kazi Helal reports from JP Morgan's healthcare conference in San Francisco, where three approaches emerged for the next phase of the obesity drug market:
  • Building on the GLP-1 drug market by focusing on medications that treat side effects like muscle or bone loss and skin aesthetics—which, while not ideal medically, are favored by investors and M&A in the short term

  • The evolution of GLP-1 2.0, exemplified by MBX Biosciences, which aims to enhance existing biology through improved dosage and user-friendliness

  • Entirely new approaches, as demonstrated by Rivus Pharma, which is experimenting with metabolic accelerators competing with energy-intake GLP-1 drugs
Share: Email LinkedIn Twitter Facebook
Mapping France's muted VC ecosystem
(SCStock/Getty Images)
In 2023, VC dealmaking in France came in significantly below 2022's figures, but the country's declines were more muted than those of its peers, including the UK.

Check out our snapshot of the French market to see how the country fared across venture dealmaking, fundraising and exits.
read more
 
Share: Email LinkedIn Twitter Facebook
 
Since yesterday, the PitchBook Platform added:
9
VC valuations
1726
People
501
Companies
28
Funds
See what our data software can do
 
The Daily Benchmark:
2018 Vintage European Debt Funds
Median IRR
8.08%
Top Quartile IRR
10.33%
0.38x
Median DPI
Select top performers
ICG Europe VII
Alchemy Special Opportunities Fund IV
Crescent European Specialty Lending Fund II
*IRR: net of fees
20 Funds in Benchmark Â»
Check out the latest version of PitchBook Benchmarks
 
VC Deals  
Genomics raised ÂŁ35 million led by F-Prime Capital and Foresight Partners, the Financial Times reported. The UK-based startup focuses on predicting and preventing common diseases by analyzing gene variations.

Vortexa, which offers an analytics platform for energy and freight, raised a $34 million Series C led by Morgan Stanley Expansion Capital.

Recurrent, an electric vehicle battery data company, raised a $16 million Series A led by ArcTern Ventures.

Imbed Biosciences, a tissue engineering company, raised $10 million in convertible debt with participation from Niterra.

Plant-based meat company Mush Foods raised a $6.2 million seed round led by Viola Ventures, Axios reported.

Singapore-based fintech startup Fynxt closed a $5 million Series A.

New York-based acupuncture company Wthn secured a $5 million Series A led by L Catterton.

Cleva, the San Francisco-based provider of a banking platform for emerging markets, raised $1.5 million led by 1984 Ventures.
 
Don't miss our upcoming webinar
Join our analysts as they recap the biggest 2023 trends in European PE and VC and help you get prepared for 2024. Whether you're interested in dealmaking considerations, exit market conditions, potential risks ahead or updates on raised capital, our experts will help you win what's next.

Register now to secure your spot.
Share: Email LinkedIn Twitter Facebook
 
PE Deals  
Bain Capital's takeover of SoftwareOne may come to a standstill after the Swiss software provider signaled to Bain that its latest offer falls short of winning approval from the company's board, Bloomberg reported. Bain's revised offer of almost 3 billion Swiss francs (about $3.5 billion) marks the latest twist in a monthslong bidding process.

McIntyre Partners agreed to buy Norwegian offshore engineering specialist Moreld from HitecVision.

CVC Capital Partners is in talks to buy Gruppo La Piadineria from Permira in a deal that could value the Italian restaurant chain at more than $300 million, Il Sole 24 Ore reported. Permira acquired La Piadineria in 2018.

Thoma Bravo invested in BlueMatrix, an investment research publisher. Golub Capital provided debt financing for the deal.
 
Exits & IPOs  
The Raine Group and Temasek are looking to sell SoundCloud in a deal that could value the Berlin-based music streaming service at more than $1 billion, Sky News reported.

Bain Capital is weighing the sale of Centrient Pharmaceuticals, an antibodies manufacturer that Bain acquired in 2018, Bloomberg reported. Bain reportedly enlisted Citigroup and Jefferies Financial Group to work on the divestment, which could value Centrient at as much as €1 billion.
 
Fundraising  
Joshua Kushner's VC firm Thrive Capital is in early talks to raise at least $3 billion from investors for a new fund, the Financial Times reported. The firm has backed payment giant Stripe and generative AI leader OpenAI.

Blackstone has raised $1.3 billion for a private equity fund backed by individual investors called BXPE, according to a regulatory filing.

VC firm Venrock has closed its tenth fund with $650 million, Fortune reported. The new vehicle is a significant step up from Venrock's last fund, which raised $450 million in 2021.
 
Investors  
Coatue is closing its London office just two years after opening it as the firm reorganizes its VC strategy, according to reports.
 
Chart of the Day  
Source: Vertical Opportunities in a Reopened IPO Window
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

PitchBook Data Inc., 901 Fifth Avenue, Suite 1200, Seattle WA 98164, United States

© 2024 PitchBook. Win what's next. All rights reserved.

Older messages

3 VC sectors feel extra pressure for returns

Monday, January 8, 2024

Carbon recycling offers sustainable investments; Vico Therapeutics secures $60M Series B; TCG Crossover wraps up $1B second fund Read online | Don't want to receive these emails? Manage your

PE needs to get creative in 2024

Sunday, January 7, 2024

Plus: A first look at the PitchBook-NVCA Venture Monitor, semiconductors lose luster with VC, a liquidity crunch & more Read online | Don't want to receive these emails? Manage your

A first look at 2023 VC data

Saturday, January 6, 2024

Also: December performance across the global markets; Diving into VC-backed IPO opportunities by vertical; Tech research on semiconductor scale-ups... Read online | Don't want to receive these

Gen AI services startups find a niche

Friday, January 5, 2024

December's equity, debt and commodities trends; ranking European VC's top investors; OnCusp Therapeutics rakes in $100M Read online | Don't want to receive these emails? Manage your

A preview of VC's final 2023 data

Thursday, January 4, 2024

Preliminary PE data charts the decline; crypto VC weighs similarities to generative AI craze; PE is optimistic for exit rebound Read online | Don't want to receive these emails? Manage your

You Might Also Like

🚨 We’re Going LIVE! 🚨Ask Me Anything B2B Marketing is Starting

Monday, September 16, 2024

Here Is The Link To Join! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

🎙️ Free Webinar Tomorrow: Get Expert B2B Marketing Advice

Monday, September 16, 2024

🚨 Free Webinar Tomorrow! Last Chance To RSVP! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

The $200/day Facebook side hustle...

Monday, September 16, 2024

A couple years ago, I never would have thought I'd be making money directly on Facebook, through the performance bonus program. However, at the beginning of this month, I've been making nearly

SEC Drops Term ‘Crypto Asset Securities’ in Binance Case

Monday, September 16, 2024

September 16, 2024 | Read Online SEC Drops Term 'Crypto Asset Securities' in Binance Case Plus Markets Price in Jumbo 50bps Rate Cut for Fed Meeting fb fb fb fb The Breakdown First Five -

What do you do when your product launch fails? [Roundup]

Monday, September 16, 2024

Hey Reader, If you've sold on Amazon for a while, you'll (inevitably) learn that products get old fast. Either you run out of stock and sales aren't what it used to be or product sales just

What channels move the needle for agencies

Monday, September 16, 2024

How agencies are aligning marketing strategies with consumer behavior ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

All Eyes On The Federal Reserve This Week

Monday, September 16, 2024

Today's letter is brought to you by Domain Money! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Prompting with AI templates

Monday, September 16, 2024

Today's Guide to the Marketing Jungle from Social Media Examiner... Presented by social-media-marketing-world-logo It's National Collect Rocks Day, Reader... Go fill those pockets! In

Behind Mr. Ballen’s true crime kingdom 💀

Monday, September 16, 2024

The man. The myth. And his 8-figure business. Trends logo If you don't love emotional rollercoasters with missing persons, murder mysteries, and macabre intentions on otherwise quiet commutes,

Huntress secures revenue milestone

Monday, September 16, 2024

Mid-market deals spark revival; checking up on healthcare funds; VC dealmaking for India's unicorns stalls Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: